biodexa-logo-square (1).png
ADR Ratio Change
19 sept. 2024 16h30 HE | Biodexa Pharmaceuticals PLC
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PDD Holdings f/k/a Pinduoduo
19 sept. 2024 11h49 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In PDD To Contact Him Directly To Discuss Their Options If you...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix
19 sept. 2024 11h38 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Orthofix To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Starbucks
19 sept. 2024 11h32 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Starbucks To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GitLab
19 sept. 2024 11h31 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In GitLab To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
19 sept. 2024 11h20 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Super Micro Computer
19 sept. 2024 11h13 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Super Micro Computer To Contact Him Directly To Discuss Their...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CrowdStrike
19 sept. 2024 10h53 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In CrowdStrike To Contact Him Directly To Discuss Their Options ...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics
19 sept. 2024 10h43 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If you...
James (Josh) Wilson Faruqi & Faruqi, LLP
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
19 sept. 2024 10h41 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lifecore To Contact Him Directly To Discuss Their Options If...